Abiomed receives close-out letter from FDA Abiomed announced that on February 19, Abiomed received a close-out letter from the FDA, Office of Compliance with respect to its previous FDA warning letter dated June 10, 2011. The close-out letter states that the FDA Office of Compliance has completed its evaluation of the corrective actions taken by Abiomed in response to the previously disclosed FDA warning letter and that the concerns cited in that letter appear to have been addressed.
News For ABMD From The Last 14 Days
Check below for free stories on ABMD the last two weeks.
Subscribe for More Information